Alpibectir

DB21561InvestigationalSmall molecule

Alpibectir is a small molecule drug. Alpibectir is under investigation in clinical trial NCT06748937 (A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide).... Alpibectir has a monoisotopic molecular weight of 332.1 Da.

Formula / weight: C₁₂H₁₄F₆N₂O₂ · 332.246 g/mol (avg)

Resolves to

Compound

UNIICC5WUX826WCAS2285440-39-1ChEMBLCHEMBL5095086

Structure

InChIKeyZEAVKHMQTZBUND-UHFFFAOYSA-NSMILESFC(F)(F)CCC(=O)N1CCC2(CC(=NO2)C(F)(F)F)CC1

Transporters

P08183ABCB1Q9UNQ0ABCG2

What you can answer from here — as of September 16, 2026

2TransportersSubstrate / inhibitor direction, not just membership

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Alpibectir, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account